| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 1EQV5MLY3D |
| InChI Key | XOAAWQZATWQOTB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C2H7NO3S |
| Molecular Weight | 125.15 |
| AlogP | -1.17 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 80.39 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 7.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 3.739 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -1.72--0.93 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
10000 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC36 family of proton-coupled amino acid transporters
|
- | - | - | 7800000 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Xerostomia | 3 | D014987 | ClinicalTrials |
| Hypertension | 3 | D006973 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Mental Disorders | 2 | D001523 | ClinicalTrials |
| Bipolar Disorder | 2 | D001714 | ClinicalTrials |
| Homocystinuria | 1 | D006712 | ClinicalTrials |
| Multiple Sclerosis | 1 | D009103 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 107-35-7 |
| ChEBI | 15891 |
| ChEMBL | CHEMBL239243 |
| DrugBank | DB01956 |
| DrugCentral | 4486 |
| EPA CompTox | DTXSID3021304 |
| FDA SRS | 1EQV5MLY3D |
| Human Metabolome Database | HMDB00251 |
| Guide to Pharmacology | 2379 |
| KEGG | C00245 |
| PDB | TAU |
| PubChem | 1123 |
| SureChEMBL | SCHEMBL23068 |
| ZINC | ZINC000003809490 |